Rtw Investments »

Atai Life Sciences Nv shares owned by Rtw Investments

Quarter-by-quarter ownership of Atai Life Sciences Nv shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Atai Life Sciences Nv

Tip: Access up to 7 years of quarterly data

All positions including Atai Life Sciences Nv held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atai Life Sciences Nv by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.2M 2.0M 4.09

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Cogent Biosciences (COGT)
Penumbra (PEN)
Irhythm Technologies (IRTC)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
ACADIA Pharmaceuticals (ACAD)
Establishment Labs Holdings Ord (ESTA)

View all positions for Rtw Investments

Top funds holding Atai Life Sciences Nv

Adage Capital Partners GP
Deep Track Capital
Citadel Advisors
BlackRock
Rtw Investments
Ally Bridge Group
Eagle Health Investments
Hrt Financial
Qube Research & Technologies
Millennium Management
Goldman Sachs Group
Moore Capital Management
Point72 Asset Management
ADAR1 Capital Management
Jane Street

View all funds holding Atai Life Sciences Nv